Aslanova Kh. R.

SOME RESULTS AND PROSPECTS OF THE STUDY OF HELICOBACTER PYLORI INFECTION


About the author:

Aslanova Kh. R.

Heading:

CLINICAL AND EXPERIMENTAL MEDICINE

Type of article:

Scentific article

Annotation:

Today, Helicobacter pylori-associated diseases due to the high level of prevalence, side effects of drugs and the formation of antibiotic resistance are a serious and still unsolved medical and social problem. Objective: to study the epidemiological features and dynamics of the prevalence of Helicobacter pylori infection among the population of different age groups. Methods. Clinical observations and examinations of 100 children and adolescents aged 13 to 18 years (51 boys, 49 girls) with a verified diagnosis of chronic gastroduodenal pathology associated with H. pylori based on the Infectious Diseases Clinic were conducted. Clinical analysis consisted in collecting anamnesis, patient complaints, objective examination data, as well as instrumental and laboratory research methods. Results. Cases of tobacco smoking are significantly more common only among boys of the oldest age group. Other factors, which include living conditions, the child’s living in an incomplete family, did not reveal statistically significant differences between age groups. Analyzing certain statistical data, it can be noted that in all patients with a high degree of colonization of H. pylori during endoscopic examination, erosion, localized on the gastric mucosa, was identified in almost all the subjects. Conclusion. The high degree of colonization of H. pylori significantly correlates with the presence of erosive lesions

Tags:

Helicobacter pylori, prevalence, contamination, erosion.

Bibliography:

  1.  Agreus L, Kuipers EJ, Kupcinskas L, Malfertheiner P, Francesco Di Mario, Leja M, et al. Rationale in diagnosis and screening of atrophic gastritis with stomach-specifi c plasma biomarkers. Scand Journal Gastroenterol. 2012;47:136-47.
  2.  O’Connor A, Gisbert JP, McNamara D, O’Morain C. Treatment of Helicobacter pylori infection. Helicobacter. 2010;15(1):46-52.
  3. Kikuchi R, Abe Y, Iijima K. Low serum levels of pepsinogen and gastrin 17 are predictive of extensive gastric atrophy with high risk of early gastric cancer. Tohoku J Exp Med. 2011;223:35-44.
  4.  Кurilovich SA, Belkovets AV, Reshetnikov OV. The first steps in the development of gastric cancer riskometry: the Siberian retrospective casecontroll study. Gastroenterology. 2014;146(5):337-8.
  5. Cukanov VV, Amel’chugova OS, Butorin NN, Tret’jakova OV, Vasjutin AV. Sovremennye aspekty jeradikacii Helicobacter pylori. Terapevticheskij arhiv. 2013;2:73-5. [in Russiаn].
  6.  Lee HJ, Kim JI, Lee JS. Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies. World J Gastroenterol. 2015;21(1):351-9.
  7. O’Connor A, Vaira D, Gisbert JP, O’Morain C. Treatment of Helicobacter pylori infection 2014. Helicobacter. 2014;19(1):38-45.
  8.  Papastergiou V, Georgopoulos SD, Karatapanis S. Treatment of Helicobacter pylori infection: Meeting the challenge of antimicrobial resistance. World J Gastroenterol. 2014;20(29):9898-911.
  9.  Megraud F, Coenen S, Versporten A, Kist M, Lopez-Brea M, Hirschl AM, et al. Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut. 2013;62(1):34-42.
  10.  Miftahussurur M, Yamaoka Y. Appropriate firstline regimens to combat Helicobacter pylori antibiotic resistance: an Asian perspective. Molecules. 2015;20(4):6068-92.

Publication of the article:

«Bulletin of problems biology and medicine» Issue 1 Part 2 (149), 2019 year, 111-114 pages, index UDK 616.98: 616.3

DOI: